News

The peremptory announcement that the UK will withdraw from the EU Atomic Energy Community risks a talent drain and leaves unanswered questions over funding for nuclear science and the future of the Joint European Torus

Will research fare better if Scotland remains part of the UK, or does Brexit mean academics should change their spots and vote for an independent country if there is another referendum? Science|Business tests the mood

Commission says new guarantee scheme will unlock €220 million for 800 Finnish businesses

Research will support the modernisation and independence of Europe’s arms manufacturers, but the sensitive nature of the work means there will not be the usual oversight and scrutiny of the programme by experts or MEPs

Eighteen EIT-backed companies make magazine’s annual selection of top innovations

Europe’s health technology assessment bodies want to know that products which show efficacy in clinical trials will work in their health systems. Companies are now required to collect real world evidence on patient outcomes says Mirella Marlow, Programme Director at NICE

The Irish government plans to apply the new indicators in all the medical centres in the country, to improve the collection and quality of health and social care data.

Researcher and physicians from several Canadian universities reported on the effectiveness of abbreviated forms of patient reported outcomes (PRO) measures to inform health professionals about patients with a comparatively severe prognosis of colorectal cancer.

Work is needed to reduce the barriers to electronic reporting of patients’ symptoms in between clinical visits, according to Ethan Basch, director of the UNC Lineberger Cancer Outcomes Research Programme, writing in the New England Medical Journal.

Scientists at the Henry Ford Hospital in Detroit and the Rush University Medical Center have highlighted potential barriers to the implementation of patient reported outcome measures for patients that suffer from severe forms of disability and injury.